Fatty change of the pancreas: the Pandora's box of pancreatology

Lancet Gastroenterol Hepatol. 2023 Jul;8(7):671-682. doi: 10.1016/S2468-1253(23)00064-X. Epub 2023 Apr 21.

Abstract

Prevention of common diseases of the pancreas or interception of their progression is as attractive in theory as it is elusive in practice. The fundamental challenge has been an incomplete understanding of targets coupled with a multitude of intertwined factors that are associated with the development of pancreatic diseases. Evidence over the past decade has shown unique morphological features, distinctive biomarkers, and complex relationships of intrapancreatic fat deposition. Fatty change of the pancreas has also been shown to affect at least 16% of the global population. This knowledge has solidified the pivotal role of fatty change of the pancreas in acute pancreatitis, chronic pancreatitis, pancreatic cancer, and diabetes. The pancreatic diseases originating from intrapancreatic fat (PANDORA) hypothesis advanced in this Personal View cuts across traditional disciplinary boundaries with a view to tackling these diseases. New holistic understanding of pancreatic diseases is well positioned to propel pancreatology through lasting research breakthroughs and clinical advances.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Gastroenterology*
  • Humans
  • Pancreas
  • Pancreatic Diseases* / complications
  • Pancreatic Diseases* / therapy
  • Pancreatitis* / complications
  • Pancreatitis* / therapy